T. Murray
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Radiopharmaceutical Chemistry and Applications 9
- Radiation Dose and Imaging 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- T. E. Hilditch (11 shared papers)Enrico Frigerio (1 shared paper)Alison H. Thomson (1 shared paper)Sally S. Burtles (1 shared paper)Daniela Fraier (1 shared paper)Stan B. Kaye (1 shared paper)Paul Austin Vasey (1 shared paper)Rachel A. Morrison (1 shared paper)
- Journals
- Nuclear Medicine Communications (9 papers)British Journal of Cancer (1 paper)Health Physics (1 paper)Journal of Labelled Compounds and Radiopharmaceuticals (1 paper)International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
T. Murray
15 papers receiving 702 citations
Peers
Comparison fields: 5 of 56
- Biomaterials 458
- Pharmaceutical Science 89
- Drug Discovery 2
- Molecular Medicine 33
- Radiology, Nuclear Medicine and Imaging 75
Countries citing papers authored by T. Murray
This map shows the geographic impact of T. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Murray more than expected).
Fields of papers citing papers by T. Murray
This network shows the impact of papers produced by T. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Murray. The network helps show where T. Murray may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. | 1999 | 621 |
| 2 | Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma. | 1986 | 31 |
| 3 | 1991 | 30 | |
| 4 | 1992 | 19 | |
| 5 | 1990 | 8 | |
| 6 | 2000 | 8 | |
| 7 | 1986 | 6 | |
| 8 | 1990 | 6 | |
| 9 | 1991 | 3 | |
| 10 | 1988 | 1 | |
| 11 | 1994 | 1 | |
| 12 | 1995 | 1 | |
| 13 | 2000 | 1 | |
| 14 | 2003 | 1 | |
| 15 | 2004 | 1 |
About T. Murray
T. Murray is a scholar working on Radiology, Nuclear Medicine and Imaging, Hepatology, Biomaterials, Endocrinology, Diabetes and Metabolism and Oncology, having authored 15 papers that have together received 738 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (9 papers), Pulmonary Hypertension Research and Treatments (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Radiation Dose and Imaging (1 paper), Thyroid Cancer Diagnosis and Treatment (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper). The work is most often cited by research in Biomaterials (458 citations), Pharmaceutical Science (89 citations), Drug Discovery (2 citations), Molecular Medicine (33 citations) and Radiology, Nuclear Medicine and Imaging (75 citations). T. Murray has collaborated with scholars based in United Kingdom. Frequent co-authors include T. E. Hilditch, Enrico Frigerio, Alison H. Thomson, Sally S. Burtles, Daniela Fraier, Stan B. Kaye, Paul Austin Vasey, Rachel A. Morrison, J Cassidy and Chris J. Twelves. Their work appears in journals such as Nuclear Medicine Communications, British Journal of Cancer, Health Physics, Journal of Labelled Compounds and Radiopharmaceuticals and International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.